Yes, the product can be applied to scalp lesions of psoriasis or seborrhoeic dermatitis. Use a small amount and massage gently; avoid excessive application to minimize systemic absorption.
Stop application immediately and contact a healthcare professional. Large-area use may increase the risk of systemic side effects, and the clinician may advise monitoring cortisol levels.
It may be used on facial skin for short periods if the prescriber deems it necessary, but the face is more prone to atrophy. Prefer lower-potency steroids for facial lesions when possible.
Temovate is a very high-potency corticosteroid, whereas OTC hydrocortisone products are low-potency. The stronger anti-inflammatory effect of Temovate makes it suitable for resistant conditions but also carries higher risk of side effects.
Do not wash or rinse the area for at least 2 hours after application to allow optimal absorption.
Topical clobetasol is not typically screened in standard anti-doping tests, but high-dose or extensive use could be detectable. Athletes should consult their governing body’s medication guidelines.
UK-marketed Temovate tubes often display the brand name, strength “0.05 %”, and the manufacturer’s logo. Specific batch numbers and expiry dates are printed on the label.
Do not flush the medication down the toilet. Dispose of the empty tube and any remaining product according to local pharmacy-take-back programmes or follow the “Do not crush” instructions on the label.
Use only if the potential benefit outweighs the risk. Discuss with a healthcare provider; topical corticosteroids can cross the placenta in small amounts, and safer alternatives are preferred when possible.
With once-daily application to a limited area, a 15 g tube usually lasts 2-3 weeks. Usage varies with the size of the treated surface and amount applied per dose.
Temovate 0.05% contains the active ingredient clobetasol propionate, a synthetic corticosteroid used for skin conditions that require potent anti-inflammatory and immunosuppressive treatment. In the United Kingdom, it is classified as a prescription-only medicine (POM) and is supplied in a tube containing either 15 g or 30 g of product. The medication belongs to the skin-care therapeutic class and is marketed under the brand name Temovate, among other possible brand names.
Clobetasol propionate is a high-potency topical corticosteroid. It penetrates the skin and binds to intracellular glucocorticoid receptors, forming a complex that migrates to the cell nucleus. This complex modulates gene transcription, resulting in:
These actions lead to rapid relief of redness, swelling, and itching. The drug’s onset of action is typically within a few hours, with peak effects observed after several days of consistent use. Because it is applied topically, systemic absorption is limited, but prolonged use on large surface areas can result in measurable plasma levels.
Temovate 0.05% is approved by the MHRA for short-term treatment of the following dermatological conditions:
The medication is intended for adult and adolescent patients (≥12 years) when a high-potency corticosteroid is clinically justified.
Research has explored clobetasol propionate for several off-label indications, though none are formally approved in the UK:
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
If any of these serious signs occur, discontinue the medication and seek immediate medical attention.
Patients should inform their healthcare provider of all medicines, supplements, and herbal products before starting Temovate 0.05%.
Dosing must be individualized; the information above reflects typical practice for the 0.05 % strength available in 15 g and 30 g tubes.
This article provides educational information about Temovate 0.05% and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
